Ristocetin-Induced Platelet Aggregation (RIPA) and RIPA Mixing Studies
Author:
Publisher
Springer New York
Link
http://link.springer.com/content/pdf/10.1007/978-1-4939-7196-1_35
Reference12 articles.
1. Favaloro EJ, Lippi G, Franchini M (2010) Contemporary platelet function testing. Clin Chem Lab Med 48:579–598
2. Howard MA, Firkin BG (1971) Ristocetin: a new tool in the investigation of platelet aggregation. Thromb Diath Haemorrh 26:362–369
3. Howard MA, Sawers RJ, Firkin BG (1973) Ristocetin: a means of differentiating von Willebrand’s disease into two groups. Blood 41:687–690
4. Favaloro EJ (2008) Phenotypic identification of platelet type-von Willebrand disease and its discrimination from type 2B von Willebrand disease: a question of 2B or not 2B? A story of non-identical twins? Or two-sides of a multi-denominational or multi-faceted primary haemostasis coin? Semin Thromb Hemost 34:113–127
5. Favaloro EJ, Patterson D, Denholm A, Mead S, Gilbert A, Collins A, Estell J, George PM, Smith MP (2007) Differential identification of a rare form of platelet-type (pseudo-) von Willebrand disease from type 2B VWD using a simplified ristocetin-induced-platelet-agglutination (RIPA) mixing assay and confirmed by genetic analysis. Br J Haematol 139:623–626
Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. von Willebrand disease;Nature Reviews Disease Primers;2024-07-25
2. von Willebrand Disease;Reference Module in Biomedical Sciences;2024
3. Letter in response to Othman & Favaloro “Comparison of two ways of performing ristocetin-induced platelet agglutination (RIPA) mixing study for diagnosis of type 2B VWD”;Research and Practice in Thrombosis and Haemostasis;2023-08
4. Challenges in the classification of von Willebrand disease with a limited test panel: An experience from an upcoming hemostasis laboratory in southern India;Journal of Hematology and Allied Sciences;2023-07-15
5. Comparison of 2 ways of performing ristocetin-induced platelet agglutination mixing study for diagnosis of type 2B von Willebrand disease. Response to the publication of Soleimani et al;Research and Practice in Thrombosis and Haemostasis;2023-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3